Ahmed Jarmouni
Given the good announcement, it is advisable to buy this share
But beware, she has to break higher than yesterday's fence:
Gilead Sciences, Inc
GILD
announced Monday it was seeking complete FDA approval for its drug Remdesivir, which is being used in the treatment of COVID-19.
But beware, she has to break higher than yesterday's fence:
Gilead Sciences, Inc
GILD
announced Monday it was seeking complete FDA approval for its drug Remdesivir, which is being used in the treatment of COVID-19.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.